Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222285 · ClinicalTrials.gov registry record · NA
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
A NA study of Autistic Disorder, sponsored by Enzymotec.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 2
- Study locations
NCT02222285 is a NA study of Autistic Disorder that has completed, run by Enzymotec. The registered enrollment target is 56 participants, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (50% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02222285, a NA study of Autistic Disorder, has completed, sponsored by Enzymotec.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary study objective is to evaluate the efficacy of Vayarin\_005 on ASD related symptoms in children.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Medical Food : Vayarin_005
Study Locations (2)
New Jersey
- Institute of Neurology and Neurosurgery at St. Barnabas - Livingston
New York
- Spectrum Neuroscience and Treatment Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02222285
The ClinicalTrials.gov registry entry for NCT02222285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (50% lower). The listed sponsor is Enzymotec, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02222285 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT02222285 about?
NCT02222285 is a clinical study titled "An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)". The primary study objective is to evaluate the efficacy of Vayarin\_005 on ASD related symptoms in children.
What is the current status of trial NCT02222285?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2014-08. Estimated completion is 2017-10.
What conditions does trial NCT02222285 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT02222285?
The interventions under investigation include: Placebo (OTHER), Medical Food : Vayarin_005 (OTHER).
Who is sponsoring clinical trial NCT02222285?
This trial is sponsored by Enzymotec, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02222285 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
-
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.